The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HCRN GI16-288: A phase II trial of perioperative CV301 vaccination in combination with nivolumab and systemic chemotherapy for resectable hepatic-limited metastatic colorectal cancer—Preliminary efficacy and correlative results.
 
Kristen Renee Spencer
Consulting or Advisory Role - Caris Life Sciences; Helsinn Therapeutics; Lynx Group; QED Therapeutics
 
Howard S. Hochster
Stock and Other Ownership Interests - Compass Therapeutics; Processa Pharmaceuticals
Consulting or Advisory Role - Bayer; Genentech; Merck
Speakers' Bureau - Natera
 
Patrick M Boland
Consulting or Advisory Role - Bayer; Guardant Health; Merck; Pfizer
Research Funding - Amgen (Inst); Macrogenics (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)
 
Lyudmyla Derby Berim
No Relationships to Disclose
 
Timothy Kennedy
No Relationships to Disclose
 
Miral Grandhi
No Relationships to Disclose
 
Russell C Langan
Consulting or Advisory Role - Eon Health; MobileSmith
 
Dirk F. Moore
No Relationships to Disclose
 
Michael P. Kane
No Relationships to Disclose
 
Smitha S. Krishnamurthi
Research Funding - Aravive (Inst); Bristol-Myers Squibb (Inst); Natera (Inst); Pfizer (Inst)
 
Skye C. Mayo
No Relationships to Disclose
 
Anup Kasi
Research Funding - Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Agustin Pimentel
Stock and Other Ownership Interests - biontech; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; QED Therapeutics; Taiho Pharmaceutical
Research Funding - Array BioPharma (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Halozyme (Inst); Hookipa Biotech (Inst); Hoosier Cancer Research Network (Inst); Isofol Medical (Inst); Ludwig Institute for Cancer Research (Inst); Turnstone Bio (Inst); Turnstone Bio (Inst)
 
Darren R. Carpizo
Stock and Other Ownership Interests - Z53 Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - (THIO) Semicarbazone derivates and their use for treating cancer; (THIO, OXO, and SELENO) Semicarbazone complexes with Zinc and their use for treating cancer; (THIO, OXO, and SELENO) Semicarbazone complexes with zinc and their use for treating cancer; (THIO, OXO, and SELENO) Semicarbazone complexes with zinc and their use for treating cancer; Hydrazone derivatives for the treatment of cancer; Pharmaceutical compounds and therapeutic methods; Pharmaceutical compounds and therapeutic methods; Pharmaceutical compounds and therapeutic methods; Zinc complexes of hydrazones and (THIO)Semicarbazones and their use for treatment of cancer